Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-005969
Filing Date
2021-03-10
Accepted
2021-03-10 16:07:56
Documents
1
Period of Report
2021-03-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4035
  Complete submission text file 0001567619-21-005969.txt   5386
Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
OMENN GILBERT S (Reporting) CIK: 0001184227 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 21729748

Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Issuer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations